Weiss Asset Management’s Theravance Biopharma TBPH Stock Holding History

Weiss Asset Management’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121M	Hold	7,457,060	–	–	2.05%	8
2025 Q4	$140M	Hold	7,457,060	–	–	1.84%	8
2025 Q3	$109M	Hold	7,457,060	–	–	1.26%	16
2025 Q2	$82.3M	Hold	7,457,060	–	–	0.94%	13
2025 Q1	$66.6M	Hold	7,457,060	–	–	1.33%	14
2024 Q4	$70.2M	Hold	7,457,060	–	–	1.31%	14
2024 Q3	$60.1M	Hold	7,457,060	–	–	1.31%	12
2024 Q2	$63.2M	Hold	7,457,060	–	–	2.39%	5
2024 Q1	$66.9M	Hold	7,457,060	–	–	2.3%	7
2023 Q4	$83.8M	Hold	7,457,060	–	–	4%	3
2023 Q3	$64.4M	Hold	7,457,060	–	–	3.81%	5
2023 Q2	$77.2M	Hold	7,457,060	–	–	5.92%	3
2023 Q1	$80.9M	Hold	7,457,060	–	–	5.18%	2
2022 Q4	$83.7M	Hold	7,457,060	–	–	3.41%	2
2022 Q3	$75.6M	Buy	7,457,060 +1,219,622	+20%	+$11.4M	1.86%	4
2022 Q2	$56.5M	Buy	6,237,438 +824,951	+15%	+$7.6M	1.38%	11
2022 Q1	$51.7M	Buy	5,412,487 +2,810,709	+108%	+$27.5M	1.07%	13
2021 Q4	$28.8M	Buy	+2,601,778	New	+$22.7M	0.62%	26

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weiss Asset Management's TBPH Position: Q1 2026 in Review

Weiss Asset Management held its Theravance Biopharma (TBPH) position steady in Q1 2026 at 7,457,060 shares worth $121M. The position accounts for 2.05% of the portfolio, ranked #8.

Weiss Asset Management first reported a position in TBPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $140M in Q4 2025. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

Weiss Asset Management held 7,457,060 shares of Theravance Biopharma worth $121M as of Q1 2026.
Weiss Asset Management left its Theravance Biopharma share count unchanged in Q1 2026.
Theravance Biopharma made up 2.05% of Weiss Asset Management's portfolio in Q1 2026, its #8 holding.
Weiss Asset Management first reported a position in Theravance Biopharma in Q4 2021 and has held it in 18 quarters since.
Weiss Asset Management's Theravance Biopharma position peaked at $140M in Q4 2025.
173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.